OCGN
Ocugen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.36
+0.74%Margins
Gross margin
100.0%
EBITDA margin
-1531.1%
EBIT margin
-1504.4%
Net margin
-1786.3%
FCF margin
-1340.1%
494.1%
Return on equity
-65.9%
Return on assets
-96.5%
Return on invested capital
0.05x
Asset turnover
-$61.2M
Cash from operations
$0.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026